Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
Moving Beyond Data Completeness: Ensuring RSR Data Reflect Services Being Provided
Review of 2021 RSR data and data quality issues.Resource updated 12/21/2023
-
Preparing for the RSR: A Yearlong Activity
Description of year-round activities and best practices in preparing for the Ryan White HIV/AIDS Program Services Report (RSR).Resource updated 09/19/2023
-
RSR Frequently Asked Questions
These FAQs are drawn from DISQ's webinars and other engagement with recipients. If your question isn't covered, contact us via our TA Request Form or DISQ email account.Resource updated 09/19/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
An Update on COVID-19
Review of COVID-19 risks in people with HIV (PWH), covering: risks; vaccination and prevention measures; and treatment considerations.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Preventing HIV-Related Comorbidities in Adolescents
Review of the epidemiology of adolescents living with HIV; risk factors for developing comorbidities over the life course among adolescents with HIV; and opportunities to prevent comorbidities and optimize outcomes.Resource (Conference Presentation) updated 09/14/2023
-
An Update on Screening for Non-AIDS-Defining Cancers
Review of overall trends, increased incidence, and screening regarding non-AIDS-defining cancers for people with HIV.Resource (Conference Presentation) updated 09/14/2023
-
Addressing Depression In People with HIV
Review of the differential diagnosis, management and treatment of depressive illnesses among people with HIV.Resource (Conference Presentation) updated 09/14/2023
-
Diagnosing and Managing Sexually Transmitted Infections
Review of the diagnostic and management strategies for the most common sexually transmitted infections based on the updated 2021 CDC STI Treatment Guidelines.Resource (Conference Presentation) updated 09/14/2023
-
Preexposure Prophylaxis: A Case-Based Panel Discussion
Review of options for PrEP in patients with decreased kidney function and low bone mineral density; the state of the science on STI prevention strategies; and recent data on the safety and efficacy on injectable PrEP options.Resource (Conference Presentation) updated 09/14/2023
-
ESCALATE Glossary of Terms
The purpose of the ESCALATE training program is to facilitate transformative and relational change in Ryan White HIV/AIDS Programs (RWHAP) and the communities they serve. This is a Glossary of commonly used terms under in the ESCALATE capacity-building initiative.
Resource updated 05/14/2024
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
RSR In Focus: Reporting Services Correctly in the RSR
Annually, Ryan White HIV/AIDS Program (RWHAP) funded recipients and providers are required to submit the RWHAP Services Report (RSR). The RSR includes three reports: the Recipient Report, the Provider Report and the Client-Level Data (CLD) Report (i.e., client-level data XML file).Resource updated 09/14/2023